Where the power of nature meets the logic of science for the betterment of health. More »
ChromaDex leverages its complementary business units to discover, acquire, develop and commercialize patented and proprietary ingredient technologies that address the dietary supplement, food, beverage, skin care and pharmaceutical markets. In addition to our ingredient technologies unit, we also have business units focused on natural product fine chemicals, chemistry and analytical testing services, and product regulatory and safety consulting. As a result of our relationships with leading universities and research institutions, we are able to discover and acquire early stage, ingredient technologies that are protected by intellectual property....
|03/08/18||ChromaDex Corporation Reports 2017 Financial Results |
|Fourth Quarter 2017 Net Revenues Increased by 69% to $7.5 Million
IRVINE, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corporation (NASDAQ:CDXC), a science-based, integrated nutraceutical company devoted to improving the way people age, announced today fourth quarter and full year 2017 financial results.
Results of operations for the three months ended Dec. 30, 2017
For the three months ended Dec. 30, 2017 (“Q4 2017”), ChromaDex reported net sales from continuing operations of $7.... |
|03/06/18||ChromaDex to Present at the 30th Annual ROTH Conference on March 12, 2018|
|IRVINE, Calif., March 06, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corporation (NASDAQ:CDXC), a science-based, integrated nutraceutical company devoted to pioneering technologies that improve the way people age, has been invited to present at the 30th Annual ROTH Capital Partners Conference. The conference is being held on March 11-14, 2018 at The Ritz-Carlton in Dana Point, Calif.
ChromaDex management is scheduled to present on Monday, March 12th at 7:30 a.m. Pacific time, with one-on-one meetin... |
|03/02/18||ChromaDex Sets Fourth Quarter and Full Year 2017 Conference Call for Thursday, March 8, 2018 at 4:30 p.m. ET|
|IRVINE, Calif., March 02, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corporation (NASDAQ:CDXC), a science-based, integrated nutraceutical company devoted to pioneering technologies that improve the way people age, will hold a conference call on Thursday, March 8, 2018 at 4:30 p.m. Eastern time to discuss its financial results for the fourth quarter and full year ended December 30, 2017. The financial results will be reported in a press release after the close of regular stock market trading hours on t... |
There are currently no events scheduled.
Receive E-mail Alerts|
|Sign up to receive e-mail alerts whenever Chromadex Corp posts new information to the site. Just enter your e-mail address and click Submit.|
|Data provided by Nasdaq. Minimum 15 minutes delayed.|